Quality-of-life in elderly patients one year after transcatheter aortic valve implantation for severe aortic stenosisGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
EuroIntervention 7:573-9. 2011
..Quality-of-life (QoL) is a critical measure of effectiveness of TAVI in this patient population. In this prospective study, we sought to assess one year changes in QoL in patients who underwent TAVI...
Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillationGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
Catheter Cardiovasc Interv 74:217-22. 2009
..The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure...
Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the Core Valve revalving system-technical tips and role of the Accutrak systemKunal Sarkar
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 78:485-90. 2011
..Salient technical expedients have been mentioned and discussed in detail...
Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-upGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
EuroIntervention 7:1285-92. 2012
..We investigated the causes of dislocation during TAVI of the self-expanding CoreValve ReValving™ System (CRS) (Medtronic Inc., Minneapolis, MN, USA). This included midterm follow-up of patients experiencing this acute complication...
Quality of life following percutaneous mitral valve repair with the MitraClip SystemGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Int J Cardiol 155:194-200. 2012
..QoL is a critical measure of effectiveness of this procedure. We sought to evaluate quality of life (QoL) and NYHA class following this novel procedure...
Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot studyAlessio La Manna
Division of Cardiology, Ferrarotto Hospital, Catania, Italy
J Cardiovasc Magn Reson 13:82. 2011
....
[Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?]Gian Paolo Ussia
Ospedale Ferrarotto, Universita di Catania, Catania
G Ital Cardiol (Rome) 13:356-65. 2012
..This approach that reproduces the edge-to-edge technique described by Alfieri, is safe and effective in improving functional class and reducing rehospitalization rates for heart failure patients...
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantationGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Am J Cardiol 108:1772-6. 2011
..71) and 6 months (18% vs 15%; p = 0.85). In conclusion, the strategy of adding clopidogrel to aspirin for 3 months after TAVI was not found to be superior to aspirin alone. These results must be confirmed in a larger randomized trial...
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesisGian Paolo Ussia
Interventional Structural and Congenital Heart Disease Programme, Invasive Cardiology Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
Eur Heart J 33:969-76. 2012
..We sought to assess 3-year clinical and echocardiographic outcomes of patients undergoing TAVI with the third generation CoreValve prosthesis (Medtronic Incorporation, MN, USA)...
Update on percutaneous mitral valve therapy: clinical results and real life experienceG P Ussia
Division of Cardiology, University of Catania, Catania, Italy
Minerva Cardioangiol 60:57-70. 2012
..Despite the promising results clinical experience is still small, and no data related the durability are currently available. Therefore, MitraClip device should be reserved now to high risk or inoperable patients...
The valve-in-valve technique for treatment of aortic bioprosthesis malposition an analysis of incidence and 1-year clinical outcomes from the italian CoreValve registryGian Paolo Ussia
Ferrarotto Hospital, University of Catania, Catania, Italy
J Am Coll Cardiol 57:1062-8. 2011
..We appraised the incidence and clinical outcomes of patients who were treated with the valve-in-valve (ViV) technique for hemodynamically destabilizing paraprosthetic leak (PPL)...
Aortic valve perforation during aortic valvuloplasty: Identification and strategies for preventionGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy Excellence Through Newest Advances ETNA Foundation, Catania, Italy
Catheter Cardiovasc Interv 77:876-80. 2011
..Failure to recognize cusp perforation can lead to serious procedural complications like severe aortic regurgitation, suboptimal prosthesis deployment, and function that can necessitate emergent open cardiac surgery...
Postprocedural management of patients after transcatheter aortic valve implantation procedure with self-expanding bioprosthesisGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 76:757-66. 2010
..We report our experience about postoperative management protocol adopted in our Division...
Management of implant failure during transcatheter aortic valve implantationGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
Catheter Cardiovasc Interv 76:440-9. 2010
..There is a paucity of detailed data on the management and outcome of complications related to the sub-optimal deployment of the prosthesis. We appraised the incidence and management of early implant failure occurring during TAVI...
Consequences of underexpansion of a percutaneous aortic valve bioprosthesisGian Paolo Ussia
Invasive Cardiology, Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
J Invasive Cardiol 22:E86-9. 2010
..We describe a case of CoreValve self-expanding prosthesis underexpansion, reporting data on prosthesis performance and short-term clinical outcome...
Feasibility of percutaneous transcatheter mitral valve repair with the MitraClip system using conscious sedationGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
Catheter Cardiovasc Interv 75:1137-40. 2010
..Conscious sedation may represent a convenient alternative approach for selected patients who undergo this innovative procedure...
The valve-in-valve technique: transcatheter treatment of aortic bioprothesis malpositionGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 73:713-6. 2009
....
Treatment of severe regurgitation of stentless aortic valve prosthesis with a self-expandable biological valveGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
J Invasive Cardiol 21:E51-4. 2009
..Here we describe the case of an 85-year-old female with severe regurgitation of a stentless biological prosthesis treated using the third-generation of CoreValve Revalving System...
Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experienceGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 74:607-14. 2009
..We report our experience about PFO closure with a bioabsorbable device, BioSTAR (NMT Inc, USA)...
Quality of life assessment after percutaneous aortic valve implantationGian Paolo Ussia
Division of Cardiology, Ferrarotto Hospital, University of Catania, Via Citelli 6, Catania, Italy
Eur Heart J 30:1790-6. 2009
..To assess the NYHA class and the quality of life (QoL) scores after percutaneous aortic valve implantation (PAVI) with the 18-Fr CoreValve prosthesis...
Early- and mid-term outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: a comparative analysis between different risk strataCorrado Tamburino
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 79:132-40. 2012
..To date, there is lack of clarity on data about outcomes of TAVI in lower risk patients. We sought to evaluate the outcomes of patients undergoing TAVI with LES ≥ 20% in comparison with patients with LES < 20%...
Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesisValeria Calvi
Cardiology Department, Ferrarotto Hospital, University of Catania, via Citelli 1, Catania, 95100, Sicily, Italy
J Interv Card Electrophysiol 34:189-95. 2012
..The aim of this study was to assess the incidence rate of conduction disorders and the predictors of postoperative PPM requirement in a large series of patients undergoing TAVI...
Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosisCorrado Tamburino
Cardiology Department, Ferrarotto Hospital, University of Catania, Catania, Italy
Circulation 123:299-308. 2011
....
Balloon aortic valvuloplasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantationGian Paolo Ussia
Department of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
J Invasive Cardiol 22:161-6. 2010
..Background. There are no data on BAV use as a bridge to TAVI in patients at high risk of periprocedural complications...
Accuracy of intracardiac echocardiography for aortic root assessment in patients undergoing transcatheter aortic valve implantationGian Paolo Ussia
Division of Cardiology Ferrarotto Hospital, Catania, Italy
Am Heart J 163:684-9. 2012
..We sought to appraise the accuracy of intracardiac echocardiography (ICE) in measurements of structures in the aortic root in patients undergoing TAVI...
Comparison of complications and outcomes to one year of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosisCorrado Tamburino
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Am J Cardiol 109:1487-93. 2012
..In conclusion, in a large observational registry with admitted potential for selection bias and residual confounding, TAVI was not associated with a higher risk of 1-year MACCEs compared to SAVR...
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world settingCorrado Tamburino
Cardiology Department, Ferrarotto Hospital, University of Catania, Via Citelli 6, 95124 Catania, Italy
Eur Heart J 31:1382-9. 2010
....
Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip systemSalvatore Scandura
Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy
J Am Soc Echocardiogr 25:1099-105. 2012
..However, specific data on left cardiac chambers reverse remodeling after such procedures are limited...
Percutaneous mitral valve repair in patients with prior cardiac surgerySalvatore Scandura
Cardiovascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy
J Card Surg 27:295-8. 2012
..The aim of this study was to evaluate the outcomes of patients with prior cardiac surgery undergoing MitraClip therapy (Abbott, Abbott Park, Chicago, IL, USA) for severe mitral regurgitation...
Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term resultsFrancesca Mirabella
Department of Cardiology, Ferrarotto Hospital, University of Catania, Italy
J Invasive Cardiol 21:145-50. 2009
..We sought to evaluate clinical and angiographic outcomes of percutaneous coronary intervention (PCI) in patients receiving both bare-metal stents (BMS) and drug-eluting stents (DES)...
Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experienceGian Paolo Ussia
Cardiology Division, University of Catania, Ferrarotto Hospital, Italy
J Cardiovasc Med (Hagerstown) 7:569-72. 2006
..The aim of this study was to assess the safety, feasibility and mid-term efficacy of this procedure...
Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases descriptionMarco Barbanti
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 78:650-5. 2011
....
Trans catheter aortic valve implantation with core valve revalving system in uncoiled (horizontal) aorta. Overcoming anatomical and technical challenges for successful deploymentKunal Sarkar
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 78:964-9. 2011
..Familiarity and facility with retrieval techniques using a snare catheter is desirable in cases of implant failure...
Transcatheter aortic valve implantation: what has been done and what is going to be doneCorrado Tamburino
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy and ETNA Foundation, Catania, Italy
Future Cardiol 6:83-95. 2010
..This paper aims to go over all the current devices, from the most widely used to the newest technology, focusing on device description, procedural issues, potential complications and clinical studies currently available in literature...
Images in cardiovascular medicine. Late device dislodgement after percutaneous closure of mitral prosthesis paravalvular leak with Amplatzer muscular ventricular septal defect occluderGian Paolo Ussia
Cardiovascular Department, Ferrarotto Hospital, Catania, Italy
Circulation 115:e208-10. 2007
Transesophageal echocardiography and transcranial color Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale?Sarah Mangiafico
Department of Internal Medicine and Systemic Disease, Clinical Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
J Cardiovasc Med (Hagerstown) 10:143-8. 2009
..The purpose of this study was to compare the practical use of contrast-enhanced transcranial color Doppler (c-TCD) to define its role in the diagnostic pathway of patent foramen ovale...
[Management of severe stenosis controversies and promises]Marco Barbanti
Dipartimento di Cardiologia, Ospedale Ferrarotto, Universita di Catania
Recenti Prog Med 102:374-9. 2011
..This review aims to go over some of the most hot issues currently debated on this topic...
Chronic embolization of an atrial septal occluder device: percutaneous or surgical retrieval? A case reportGian Paolo Ussia
Division of Paediatric Cardiology, Ferrarotto Hospital, Catania, Italy
J Cardiovasc Med (Hagerstown) 8:197-200. 2007
..We describe a case of late device embolization occurring two years after transcatheter atrial septal defect closure and for which percutaneous retrieval was unsuccessfully attempted...
Early conduction disorders following percutaneous aortic valve replacementValeria Calvi
Cardiology Department, Ferrarotto Hospital, University of Catania, Catania, Italy
Pacing Clin Electrophysiol 32:S126-30. 2009
..We examined the incidence and characteristics of CD in the immediate postoperative period after PAVR, and the need for permanent pacemaker (PPM) implantation...
Early restenosis after drug-eluting stent implantation: A putative role for platelet activationCorrado Tamburino
Institute of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Can J Cardiol 23:57-9. 2007
..Extremely careful follow-up is mandatory after the recognition of intraluminal thrombi inside DES because restenosis may occur at the same site of DES thrombosis...
Intracardiac echocardiography using the AcuNav ultrasound catheter during percutaneous closure of multiple atrial septal defectsGian Paolo Ussia
Pediatric Cardiology, Ferrarotto Hospital, Catania, Italy
Ital Heart J 5:392-5. 2004
..We describe the usefulness of a new phased-array ultrasound-tipped catheter for intracardiac echocardiography in a case of percutaneous closure of multiple ostium secundum atrial septal defects...
Percutaneous aortic valve replacement in a 65-year old patient with thalassemia intermedia: A case reportRosamaria Rosso
Department of Thalassemia, S Bambino Hospital, Catania, Italy
Transfus Apher Sci 43:189-92. 2010
..PARV was a safe and a valid therapeutic approach dramatically to improve the clinical evolution of cardiomyopathies in our patient...
Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valvesKunal Sarkar
Division of Cardiology, Ferrarotto Hospital, University of Catania, Italy
Catheter Cardiovasc Interv 81:864-70. 2013
..Background: TAVI has emerged as a viable treatment modality for severe aortic stenosis in inoperable or high-risk patients. The use of TAVI for treatment of severe AR has remained largely unexplored...
Mini-crush versus T-provisional techniques in bifurcation lesions: clinical and angiographic long-term outcome after implantation of drug-eluting stentsAlfredo R Galassi
Department of Internal Medicine and Systemic Disease, Clinical Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
JACC Cardiovasc Interv 2:185-94. 2009
..This retrospective study sought to assess the clinical and angiographic long-term outcome after implanting drug-eluting stents in bifurcation lesions with the T-provisional (T-prov) technique and mini-crush (MC) technique...
Reduction of mitral valve regurgitation with Mitraclip® percutaneous systemC Tamburino
Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
Minerva Cardioangiol 58:589-98. 2010
..Although the field of percutaneous management of MR is at an early stage, it has been demonstrated that percutaneous approaches can reduce MR, suggesting there is a great deal of potential for clinical benefit to patients with MR...